TY  - ADVS
AU  - Boeree,Martin
TI  - Management of MDR and XDR TB
T2  - Respiratory infection,
PY  - 2014///
CY  - London
PB  - Henry Stewart Talks
KW  - Antitubercular agents
KW  - International cooperation
KW  - Multidrug-resistant tuberculosis
KW  - Tuberculosis
KW  - Chemotherapy
KW  - Prevention
KW  - Antitubercular Agents
KW  - pharmacology
KW  - Extensively Drug-Resistant Tuberculosis
KW  - drug therapy
KW  - prevention & control
KW  - International Cooperation
KW  - history
KW  - Tuberculosis, Multidrug-Resistant
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Management of multi drug resistance (MDR) and extensive drug resistance (XDR) TB -- Management of TB before era of drug treatment -- Surgery for TB -- Drug treatment was introduced from 1943-1963 -- Rifampicin (1963) -- Timeline: discovery of drugs for TB -- Emergence of totally drug resistant TB -- Epidemiology -- Outcomes of MDR-TB treatment -- Survival curve of HIV patients with XDR TB -- Current drug treatment -- Treatment outcome in several cohorts -- Death rates in several cohorts -- Current approach for treatment of MDR/XDR TB -- WHO's programmatic management of DR TB -- Treatment recommendations -- Group 1: oral first-line agents -- Group 2: fluoroquinolones -- Group 3: injectables -- Group 4: less-effective anti-TB drugs -- Group 5: less-effective or clinical data sparse drugs -- Future drug treatment -- New compounds -- Bedaquiline (TMC207) -- The nitroimidazoles -- Thioridazine -- NC-001 (PA-824, moxifloxacine, PZA) -- Dreams and realities for the future of TB treatment; Access restricted to subscribers
UR  - https://hstalks.com/bs/2809/
UR  - https://hstalks.com/bs/p/726/
ER  -